Hemanext
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Hypoxic Red Blood Cells in Sickle Cell Anemia Sickle Cell Anaemia, Sickle Cell Anemia Crisis, Sickle Cell Anemia in Children | N/A | 2026-03-01 |
| Recruiting | Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion Hematologic Neoplasms | N/A | 2024-11-29 |
| Completed | Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital Hematologic Neoplasms, Burns | — | 2022-08-24 |
| Withdrawn | Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leuk Whole Blood Donations and Leukoreduction | Phase 2 | 2020-07-01 |
| Completed | Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial Whole Blood Donation and Leukoreduction | Phase 2 | 2017-11-27 |